Emerging infections program—state health department perspective

Emerging Infectious Diseases

Volumn 21, Issue 9, 2015, Pages 1510-1515

  Hadler, James L ^a   Danila, Richard N ^b   Cieslak, Paul R ^c   Meek, James I ^a   Schaffner, William ^d   Smith, Kirk E ^b   Cartter, Matthew L ^e   Harrison, Lee H ^f   Vugia, Duc J ^g   Lynfield, Ruth ^b  

^a YALE UNIVERSITY   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CDC   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL EFFECTIVENESS; DISEASE CONTROL; DISEASE SURVEILLANCE; FUNGAL MENINGITIS; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL INFECTION; HOSPITALIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH; SOCIOECONOMICS; STREPTOCOCCUS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; GOVERNMENT; HEALTH SURVEY; HUMAN; ORGANIZATION AND MANAGEMENT; PUBLIC RELATIONS; UNITED STATES;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; HUMANS; INTERINSTITUTIONAL RELATIONS; PUBLIC HEALTH SURVEILLANCE; STATE GOVERNMENT; UNITED STATES;

EID: 84939548656     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2109.150428     Document Type: Article

References (33)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press; 1992 [cited 2015 Jun 25]. http://iom.edu/Reports/1992/Emerging-Infections-Microbial-Threats-to-Health-in-the-United-States.aspx
2. Pinner RW. Addressing the challenges of emerging infectious disease. Am J Med Sci. 1996;311:3-8. http://dx.doi.org/1 0.1097/ 00000441-199601000-00002
3. Pinner RW, Lynfield R, Hadler JL, Schaffner W, Farley MM, Frank ME, et al. Cultivation of an adaptive domestic network for surveillance and evaluation of emerging infections. Emerg Infect Dis. 2015;21:1499-1509.
4. Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance for Escherichia coliO157:H7 infections in Minnesota by molecular subtyping. N Engl J Med. 1997;337:388-94. http://dx.doi.org/10.1056/NEJM199708073370604
5. Bender JB, Hedberg CW, Boxrud DJ, Besser JM, Wicklund JH, Smith KE, et al. Use of molecular subtyping in surveillance for Salmonella enterica serotype Typhimurium. N Engl J Med. 2001;344:189-95. http://dx.doi.org/10.1056/NEJM200101183440305
6. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-71. http://dx.doi.org/10.1001/jama.298.15.1763
7. Hadler JL, Petit S, Mandour M, Cartter ML. Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001-2010. Emerg Infect Dis. 2012;18:917-24.
8. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-208. http://dx.doi.org/10.1056/NEJMoa1306801
9. Hadler JL, Vugia DJ, Bennett NM, Moore MR. Emerging Infections Program efforts to address health equity. Emerg Infect Dis. 2015;21:1589-1594.
10. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis. 2001;184:1029-34. http://dx.doi.org/10.1086/323459
11. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-44. http://dx.doi.org/10.1056/NEJMoa043252
12. Hirshon JM, Thompson AD, Limbago B, McDonald LC, Bonkosky M, Heimer R, et al. Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007. Emerg Infect Dis. 2011;17:1946-9. http://dx.doi.org/10.3201/eid1710.110069
13. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173:1359-67. http://dx.doi.org/10.1001/jamainternmed.2013.7056
14. Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, et al. the HPV-IMPACT Working Group. The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control. 2012;23:281-8. http://dx.doi.org/10.1007/s10552-011-9877-6
15. Centers for Disease Control and Prevention. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli-Connecticut, 2000-2005. MMWR Morb Mortal Wkly Rep. 2007;56:29-31.
16. Centers for Disease Control and Prevention. Outbreak of Salmonella serotype Enteritidis infections associated with raw almonds-United States and Canada, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004;53:484-7.
17. Public Health Division, Oregon Department of Health Services. An outbreak of hemorrhagic escherichiosis traced to spinach. CD Summary 2006;55:1-2 [cited 2015 Feb 27]. https://public.health.oregon.gov/DiseasesConditions/CommunicableDisease/CDSummaryNewsletter/Documents/2006/ohd5523.pdf
18. Lujan K, Cronquist A. Outbreak # 2009-43-001-Campylobacter outbreak associated with consumption of unpasteurized milk from a cow share operation, Montrose County 2009. State of Colorado report, November 6, 2009 [cited 2015 Feb 27]. http://www.realrawmilkfacts.com/PDFs/Montrose-raw-dairy-report-Final.pdf
19. Angelo KM, Chu A, Anand M, Nguyen TA, Bottichio L, Wise M, et al. Outbreak of Salmonella Newport infections linked to cucumbers-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:144-7.
20. Slayton RB, Turabelidze G, Bennett SD, Schwensohn CA, Yaffee AQ, Khan F, et al. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with romaine lettuce consumption, 2011. PLoS ONE. 2013;8:e55300. http://dx.doi.org/ 10.1371/journal.pone.0055300
21. Centers for Disease Control and Prevention. Outbreak of Salmonella Heidelberg infections linked to a single poultry producer-13 states, 2012-2013. MMWR Morb Mortal Wkly Rep. 2013;62:553-6.
22. IJdo JW, Zhang Y, Hodzic E, Magnarelli LA, Wilson ML, Telford SR, et al. The early humoral response in human granulocytic ehrlichiosis. J Infect Dis. 1997;176:687-92. http://dx.doi.org/ 10.1086/514091
23. Bessen DE, Izzo MW, Fiorentino TR, Caringal RM, Hollingshead SK, Beall B. Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis. 1999;179:627-36. http://dx.doi.org/10.1086/314631
24. Niccolai LM, McBride V, Julian PR. Sources of information for assessing human papillomavirus vaccination history among young women. Vaccine. 2014;32:2945-7. http://dx.doi.org/10.1016/j.vaccine.2014.03.059
25. Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med. 2011;41:428-33. http://dx.doi.org/10.1016/j.amepre.2011.06.032
26. Niccolai LM, Russ C, Julian PJ, Hariri S, Sinard J, Meek JI, et al. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: associations with race, ethnicity and poverty. Cancer. 2013;119:3052-8. http://dx.doi.org/ 10.1002/cncr.28038
27. Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16:979-83. http://dx.doi.org/10.1097/00006454-199710000-00015
28. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997;94:271-6. http://dx.doi.org/10.1073/pnas.94.1.271
29. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, et al. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS ONE. 2011;6:e22997. http://dx.doi.org/10.1371/journal.pone.0022997
30. Ferrieri P, Lynfield R, Creti R, Flores AE. Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. Emerg Infect Dis. 2013;19:551-8.
31. Grijalva CG, Weinberg GA, Bennett NM, Staat MA, Craig AS, Dupont WD, et al. Estimating the undetected burden of influenza hospitalizations in children. Epidemiol Infect. 2007;135:951-8. http://dx.doi.org/10.1017/S095026880600762X
32. Vugia DJ, Meek JI, Danila RN, Jones TF, Schaffner W, Baumbach J, et al. Training in infectious disease epidemiology through the Emerging Infections Program sites. Emerg Infect Dis. 2015;21:1516-1519.
33. Public Welfare. Protection of Human Subjects. 45 CFR §46 102(d). 2009.